Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
about
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?Substance use in clinical high risk for psychosis: a review of the literatureGone to Pot - A Review of the Association between Cannabis and PsychosisCannabis use and symptom severity in individuals at ultra high risk for psychosis: a meta-analysisApproach to cannabis use disorder in primary care: focus on youth and other high-risk users.Marijuana: respiratory tract effects.Prescribing smoked cannabis for chronic noncancer pain: preliminary recommendationsCannabis use and transition to psychosis in individuals at ultra-high risk: review and meta-analysis.Impact of Cannabis Use on the Development of Psychotic DisordersSubstance use in people at clinical high-risk for psychosis.Predictors of a clinical high risk status among individuals with a family history of psychosis.Alcohol confounds relationship between cannabis misuse and psychosis conversion in a high-risk sample.Schizophrenia: from epidemiology to rehabilitation.Evaluation and treatment of children and adolescents with psychotic symptoms.Neurophysiologic effect of GWAS derived schizophrenia and bipolar risk variants."Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.Cognitive behavioral therapy program for cannabis use cessation in first-episode psychosis patients: study protocol for a randomized controlled trial.The Effect of Changes in Cannabis Exposure on Psychotic Symptoms in Patients With Comorbid Cannabis Use Disorder.Clonazepam as agonist substitution treatment for benzodiazepine dependence: a case report.Testing the hypothesis that psychotic illness begins when subthreshold hallucinations combine with delusional ideation.Substance use in individuals at clinical high risk of psychosis.Psychosis-inducing effects of cannabis are related to both childhood abuse and COMT genotypes.Approche en soins primaires pour les problèmes de consommation de cannabis: Plein feu sur les jeunes et autres usagers à risque élevé.Effect of illness expression and liability on familial associations of clinical and subclinical psychosis phenotypes.Predictive capacity of prodromal symptoms in first-episode psychosis of recent onset.Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service.Cannabis-induced attenuated psychotic symptoms: implications for prognosis in young people at ultra-high risk for psychosis.Cannabis and bipolar disorder: does quitting cannabis use during manic/mixed episode improve clinical/functional outcomes?Neurocognitive and familial moderators of psychiatric risk in velocardiofacial (22q11.2 deletion) syndrome: a longitudinal study.Early Detection and Treatment of Psychosis: The Bern Child and Adolescent Psychiatric Perspective
P2860
Q21129107-ECFAC5FE-BD56-4A1A-BE2B-CBA7B2004024Q26859349-0AEB1FAC-4E53-48C1-BBF7-F559BA48067AQ26865311-16E9F446-292F-4C4A-8A75-E5E351148650Q33834127-23DD2320-23E4-4070-866D-9A041355C779Q34173037-4129BA71-11A6-44C6-A1E3-E18D112DAA1BQ34347280-58B4FCFC-0424-446B-9737-9D38E8CC5185Q34453438-75159178-00AF-4421-867C-856F35ADD7D9Q34501767-E749E85C-E97E-4B03-AE46-AD40607D1DE6Q34668606-0436442B-387F-4EC9-B111-A2F83C9417CAQ34987780-A62C9985-5285-4D4F-8A67-76F9D2FF093FQ35168075-1088AB33-A8DE-49E5-B598-1104CB74B99EQ35955940-7BF03DE4-2A5D-46F7-85C1-AB68544C6DE4Q36210656-1A251072-DBC2-4B41-9FD1-7D9ECB71E508Q36406640-3CC4C88D-3578-440F-B6A4-CF89F14F8896Q37698539-403B9796-0F73-4E3C-A651-7FA1DCAA9F65Q38123778-C164F567-4C23-4E8A-97E5-E5CFBB0486F1Q38317405-4B19B3D9-088F-42E8-8734-EA570C9F12BFQ38389409-87567CAE-FAFE-446E-A673-B7DDC6E58BAEQ38882225-2A0F14CA-C264-4940-ABB5-2D6E066C0A7FQ43248865-E8C3C7DE-03D9-46F2-8429-C4B186709063Q44931609-6A30A51A-3E14-4826-80BA-C0F0DCD0D441Q46219681-6AE263E4-8AA6-498C-80E7-5CF8B4F69550Q46340259-4D883608-979B-4495-A5D9-0E6C0881903EQ46516634-EB0CB69A-FC63-42F9-B306-9A111A744D62Q46870611-539688A0-50FF-4AC7-A36F-79B48EA6357FQ47578112-3A1F118F-E7E4-4393-BB05-8ED75638F1EDQ47675654-8074F48C-85EF-4DD4-ADCE-9B954074729AQ47885387-8B56BCA4-8B35-429F-BE29-3095D5B700A3Q50456665-43A67EC1-7806-4ECB-9BA2-7A7F4D65D350Q50623853-6C826E93-84B8-412B-8883-36FE6809E95DQ59050567-000FDDD9-AFA5-4FB4-A2F2-97C970DBB17A
P2860
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
description
article
@en
im August 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в серпні 2011
@uk
ലേഖനം
@ml
name
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@en
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@nl
type
label
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@en
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@nl
prefLabel
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@en
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@nl
P2093
P2860
P1476
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis
@en
P2093
D. H. Linszen
D. H. Nieman
F. Schultze-Lutter
F. van der Meer
H. Graf von Reventlow
H. Stevens
J. Klosterkötter
P2860
P356
10.1111/J.1600-0447.2011.01763.X
P407
P577
2011-08-29T00:00:00Z